PharmaLists

06/28/2022

CDC Backs Moderna Vaccine for Those Aged 6 to 17

Learn more -> https://www.empr.com/home/news/cdc-backs-moderna-vaccine-for-those-aged-6-to-17/

06/07/2022

Heart Failure Hospitalization Risk Compared With Empagliflozin vs Other Glucose-Lowering Txs

Learn more ->

The EMPRISE study assessed the efficacy and safety of empagliflozin use in approximately 500,000 adults with type 2 diabetes.

05/20/2022

Gabapentin-Involved Overdose Deaths Increased Between 2019 and 2020

Learn more ->

Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.

04/29/2022

Camzyos Approved for Obstructive Hypertrophic Cardiomyopathy

Learn more ->

Camzyos is an oral, selective allosteric and reversible inhibitor of cardiac myosin.

04/22/2022

Adverse Effects Generally Mild After BNT162b2 mRNA Booster in Over 60s

Learn more -> https://www.empr.com/home/news/adverse-effects-generally-mild-after-bnt162b2-mrna-booster-in-over-60s/

04/14/2022

Pentosan Polysulfate Sodium SC Injection Fast Tracked for Osteoarthritis

Learn more -> https://www.empr.com/home/news/drugs-in-the-pipeline/pentosan-polysulfate-sodium-sc-injection-fast-tracked-for-osteoarthritis/

04/06/2022

Fetal Exposure to Cannabis Linked to Adiposity in Childhood

Learn more -> https://www.empr.com/home/news/fetal-exposure-to-cannabis-linked-to-adiposity-in-childhood/

03/30/2022

PreHevbrio Now Available for Adult Hepatitis B Vaccination

Learn more ->

03/25/2022

Nitrosamine Impurity Detected in Certain Lots of Orphenadrine Citrate ER Tablets

Learn more ->

Orphenadrine citrate ER tablet is indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.

03/23/2022

FDA Accepts Resubmitted Teplizumab BLA for T1D Delay

Learn more ->

Teplizumab is an investigational anti-CD3 monoclonal antibody that has been shown to preserve beta cell function, reducing the need for exogenous insulin.

03/18/2022

Gene Therapy for Canavan Disease Receives Multiple FDA Designations

Learn more ->

The gene therapy candidate is designed to deliver the ASPA gene directly to the oligodendrocyte cells in the fluid surrounding the brain and spinal cord.

03/16/2022

The Big Sneeze: Climate Change to Make Pollen Season Nastier
Climate scientists at the University of Michigan looked at 15 different plant pollens and used computer simulations to calculate how much worse allergy season will likely get by the year 2100.

Learn more -> https://www.medscape.com/viewarticle/970405